A modified kidney-sparing portal vein arterialization model of heterotopic auxiliary liver transplantation increases liver IL-6, TNF-α, and HGF levels and enhances liver regeneration: an animal model

BMC Surg. 2022 Jul 21;22(1):281. doi: 10.1186/s12893-022-01726-5.

Abstract

Background and aim: The success of partial donor liver transplantation is affected by the implantation site of the donor liver and the vascular reconstruction approach. We investigated the effects of different donor liver implantation sites and vascular reconstruction approaches on liver regeneration using a rat kidney-sparing heterotopic auxiliary liver transplantation model, with portal vein arterialization (PVA).

Methods: Sixty male Sprague-Dawley rats underwent end-to-end anastomosis of the donor liver portal vein and the right renal artery stent (control group), or end-to-side anastomosis of the donor liver portal vein and the left common iliac artery (experimental group).

Results: The experimental group had significantly lower plasma levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, and cholinesterase than the control group (all, P < 0.05). The levels of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and hepatocyte growth factor (HGF) in the liver were significantly higher in the experimental group than that in the control group (all, P < 0.05). Hematoxylin and eosin (HE) staining of the liver tissue specimens indicated that the experimental group had greater hepatocyte regeneration compared to the control group.

Conclusions: The modified kidney-sparing PVA model of heterotopic auxiliary liver transplantation is more conducive to liver regeneration with quicker return of liver function.

Keywords: Acute liver failure; Heterotopic auxiliary liver transplantation; Liver regeneration; Portal vein arterialization.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Hepatocyte Growth Factor
  • Humans
  • Interleukin-6
  • Kidney / surgery
  • Liver / pathology
  • Liver Regeneration
  • Liver Transplantation*
  • Living Donors
  • Male
  • Portal Vein* / surgery
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha

Substances

  • HGF protein, human
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Hepatocyte Growth Factor